Cell & Gene: The Podcast Gene Therapy Deals, Collaborations, & Partnerships with Astellas' Richard Wilson
Nov 21, 2023
Richard Wilson, Senior VP at Astellas, discusses gene therapy deal-making, Astellas' strategic approach post Audentes acquisition, building gene therapy infrastructure, advancements in gene therapy, strategic focus areas like genetic regulation and immuno-oncology, and the importance of partnerships in the cell and gene therapy sector.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Building a Comprehensive Gene Therapy Infrastructure at Estellis
01:42 • 5min
Advancements and Challenges in Gene Therapy
06:48 • 10min
Exploring Estelle's Strategic Approach to R&D and Primary Focus Areas
16:30 • 4min
Insights and Reflections on the Cell and Gene Therapy Sector Meeting
20:31 • 4min